Nifty
Sensex
:
:
25725.40
83450.96
42.65 (0.17%)
173.81 (0.21%)

Printing And Publishing

Rating :
49/99

BSE: 532440 | NSE: MPSLTD

1629.50
17-Feb-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1500
  •  1668.5
  •  1500
  •  1500.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  147049
  •  237952200.6
  •  3079
  •  1467

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,783.80
  • 14.86
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,695.50
  • 5.10%
  • 4.90

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.34%
  • 2.22%
  • 22.72%
  • FII
  • DII
  • Others
  • 1.63%
  • 0.07%
  • 5.02%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.95
  • 11.46
  • 13.20

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.85
  • 14.44
  • 6.11

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.65
  • 20.52
  • 10.90

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.13
  • 19.95
  • 23.96

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.09
  • 5.36
  • 6.87

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.70
  • 12.80
  • 15.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
182.49
186.36
-2.08%
194.44
177.70
9.42%
186.28
180.72
3.08%
182.11
149.42
21.88%
Expenses
124.91
126.02
-0.88%
133.97
124.20
7.87%
135.99
139.67
-2.63%
126.10
106.66
18.23%
EBITDA
57.58
60.34
-4.57%
60.47
53.50
13.03%
50.29
41.05
22.51%
56.01
42.76
30.99%
EBIDTM
31.55%
32.38%
31.10%
30.11%
27.00%
22.71%
30.76%
28.62%
Other Income
2.09
1.78
17.42%
2.28
1.58
44.30%
7.13
2.05
247.80%
7.10
2.51
182.87%
Interest
0.28
0.16
75.00%
0.29
0.20
45.00%
0.28
0.18
55.56%
0.24
0.35
-31.43%
Depreciation
6.30
6.87
-8.30%
6.10
6.82
-10.56%
7.01
6.84
2.49%
6.88
5.66
21.55%
PBT
45.71
55.09
-17.03%
69.17
48.06
43.92%
49.50
36.08
37.20%
61.90
39.26
57.67%
Tax
10.21
14.38
-29.00%
13.73
12.82
7.10%
14.26
10.19
39.94%
14.83
10.55
40.57%
PAT
35.50
40.71
-12.80%
55.44
35.24
57.32%
35.24
25.89
36.11%
47.07
28.71
63.95%
PATM
19.45%
21.84%
28.51%
19.83%
18.92%
14.33%
25.85%
19.21%
EPS
20.75
23.79
-12.78%
32.40
20.60
57.28%
20.60
15.13
36.15%
27.51
16.78
63.95%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
745.32
726.89
545.31
501.05
448.88
422.55
331.65
362.54
267.03
288.70
257.21
Net Sales Growth
7.36%
33.30%
8.83%
11.62%
6.23%
27.41%
-8.52%
35.77%
-7.51%
12.24%
 
Cost Of Goods Sold
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit
745.32
726.89
545.31
501.05
448.88
422.55
331.65
362.54
267.03
288.70
257.21
GP Margin
100.00%
100%
100%
100%
100%
100%
100%
100%
100%
100%
100%
Total Expenditure
520.97
517.79
375.77
345.63
322.91
316.04
252.70
269.35
181.13
195.44
167.62
Power & Fuel Cost
-
3.58
3.57
3.76
3.57
4.26
5.39
5.26
4.96
5.34
4.19
% Of Sales
-
0.49%
0.65%
0.75%
0.80%
1.01%
1.63%
1.45%
1.86%
1.85%
1.63%
Employee Cost
-
327.98
243.39
212.81
201.74
202.54
165.62
164.46
111.49
121.29
109.55
% Of Sales
-
45.12%
44.63%
42.47%
44.94%
47.93%
49.94%
45.36%
41.75%
42.01%
42.59%
Manufacturing Exp.
-
111.08
74.64
75.42
73.05
66.21
46.85
55.93
32.52
37.81
26.68
% Of Sales
-
15.28%
13.69%
15.05%
16.27%
15.67%
14.13%
15.43%
12.18%
13.10%
10.37%
General & Admin Exp.
-
52.00
39.11
39.55
33.66
33.29
24.67
32.28
21.79
21.52
20.14
% Of Sales
-
7.15%
7.17%
7.89%
7.50%
7.88%
7.44%
8.90%
8.16%
7.45%
7.83%
Selling & Distn. Exp.
-
8.25
6.05
4.23
1.34
1.15
3.83
3.33
0.73
0.00
0.00
% Of Sales
-
1.13%
1.11%
0.84%
0.30%
0.27%
1.15%
0.92%
0.27%
0%
0%
Miscellaneous Exp.
-
14.89
9.01
9.86
9.55
8.59
6.33
8.09
9.64
9.48
0.00
% Of Sales
-
2.05%
1.65%
1.97%
2.13%
2.03%
1.91%
2.23%
3.61%
3.28%
2.74%
EBITDA
224.35
209.10
169.54
155.42
125.97
106.51
78.95
93.19
85.90
93.26
89.59
EBITDA Margin
30.10%
28.77%
31.09%
31.02%
28.06%
25.21%
23.81%
25.70%
32.17%
32.30%
34.83%
Other Income
18.60
14.31
12.57
12.11
14.39
10.14
19.98
25.42
24.12
19.46
19.79
Interest
1.09
0.78
0.86
1.11
1.53
2.04
2.15
0.19
0.13
0.17
0.11
Depreciation
26.29
27.41
19.98
19.49
20.88
21.22
15.37
11.07
8.05
5.88
4.12
PBT
226.28
195.22
161.26
146.93
117.96
93.39
81.42
107.35
101.86
106.66
105.14
Tax
53.03
52.22
42.49
37.74
30.84
34.83
21.56
31.32
31.65
32.13
33.91
Tax Rate
23.44%
25.96%
26.35%
25.69%
26.14%
37.30%
26.48%
29.18%
31.07%
31.33%
32.25%
PAT
173.25
148.91
118.77
109.19
87.12
58.56
59.86
76.04
70.21
70.42
71.24
PAT before Minority Interest
173.25
148.91
118.77
109.19
87.12
58.56
59.86
76.04
70.21
70.42
71.24
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
23.25%
20.49%
21.78%
21.79%
19.41%
13.86%
18.05%
20.97%
26.29%
24.39%
27.70%
PAT Growth
32.71%
25.38%
8.77%
25.33%
48.77%
-2.17%
-21.28%
8.30%
-0.30%
-1.15%
 
EPS
101.32
87.08
69.46
63.85
50.95
34.25
35.01
44.47
41.06
41.18
41.66

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
478.43
459.81
427.15
366.87
381.12
366.91
471.16
418.68
347.90
279.43
Share Capital
17.11
17.11
17.11
17.11
18.05
18.62
18.62
18.62
18.62
18.62
Total Reserves
460.02
442.25
410.04
349.77
363.07
348.29
452.54
400.06
329.28
260.82
Non-Current Liabilities
253.57
286.11
263.26
228.35
180.71
152.55
116.67
84.13
49.36
14.10
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
221.04
219.23
237.75
208.39
157.24
136.23
110.85
79.23
44.03
12.43
Current Liabilities
166.63
242.76
131.36
136.88
129.10
59.40
88.78
58.06
59.80
114.09
Trade Payables
25.45
23.98
20.35
18.06
21.97
12.20
13.31
11.09
10.99
8.30
Other Current Liabilities
123.26
172.39
82.55
88.25
72.22
42.91
41.75
11.70
13.51
11.39
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
17.92
46.39
28.46
30.56
34.92
4.29
33.72
35.27
35.29
94.40
Total Liabilities
898.63
988.68
821.77
732.10
690.93
578.86
676.61
560.87
457.06
407.62
Net Block
341.93
386.96
179.28
142.57
153.31
113.92
101.76
47.64
47.42
35.84
Gross Block
487.14
522.09
280.72
220.91
223.70
162.79
138.72
61.09
53.64
92.45
Accumulated Depreciation
145.21
135.13
101.44
78.34
70.39
48.87
36.96
13.45
6.22
56.62
Non Current Assets
578.54
619.51
440.33
408.35
394.00
265.61
230.45
139.88
115.59
75.44
Capital Work in Progress
2.99
1.20
0.00
0.00
0.00
0.03
0.18
0.00
0.00
0.06
Non Current Investment
0.00
0.00
0.00
0.00
3.88
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
230.70
228.20
249.66
218.65
164.13
149.08
125.69
90.04
66.10
39.18
Other Non Current Assets
2.01
2.21
10.40
46.12
71.63
1.50
1.71
1.06
0.90
0.36
Current Assets
320.10
369.18
381.45
323.75
296.93
313.24
446.15
420.99
341.46
332.18
Current Investments
21.47
30.00
27.82
5.85
8.27
85.72
212.05
288.00
205.99
169.02
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
116.58
102.92
86.60
85.70
90.54
62.28
68.71
46.15
60.10
44.97
Cash & Bank
84.29
115.37
157.54
132.83
102.63
94.46
76.68
22.99
16.77
14.29
Other Current Assets
97.75
16.51
15.18
20.95
95.49
70.78
88.72
63.85
58.61
103.91
Short Term Loans & Adv.
79.89
104.38
94.30
78.42
78.20
57.63
44.31
59.99
54.01
99.99
Net Current Assets
153.46
126.42
250.08
186.87
167.83
253.84
357.37
362.92
281.67
218.09
Total Assets
898.64
988.69
821.78
732.10
690.93
578.85
676.60
560.87
457.05
407.62

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
100.90
118.04
112.82
114.88
99.37
52.74
53.63
77.58
44.67
48.82
PBT
201.13
161.26
146.93
117.96
93.39
81.42
107.35
101.86
102.55
105.14
Adjustment
13.71
15.19
17.68
16.80
17.91
5.47
-14.11
-6.42
-9.35
-8.98
Changes in Working Capital
-64.40
-16.96
-16.40
14.62
7.39
-13.15
-4.34
13.09
-15.85
-9.73
Cash after chg. in Working capital
150.44
159.49
148.21
149.37
118.70
73.74
88.90
108.53
77.35
86.44
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-49.54
-41.45
-35.39
-34.50
-19.33
-21.00
-35.27
-30.94
-32.67
-37.62
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.77
25.14
-64.74
15.36
-59.29
151.64
-3.86
-72.44
-39.78
-3.29
Net Fixed Assets
-7.03
-6.69
-8.42
-3.49
-65.21
-9.82
-1.42
-11.85
51.16
-3.54
Net Investments
11.42
-16.59
-9.23
7.78
65.68
112.20
23.05
-77.51
-59.80
-16.37
Others
-10.16
48.42
-47.09
11.07
-59.76
49.26
-25.49
16.92
-31.14
16.62
Cash from Financing Activity
-140.23
-93.37
-70.10
-115.51
-52.93
-175.31
-27.02
-0.05
-0.15
-49.41
Net Cash Inflow / Outflow
-45.10
49.81
-22.02
14.72
-12.85
29.07
22.75
5.10
4.75
-3.88
Opening Cash & Equivalents
108.01
58.01
79.48
64.54
81.70
47.52
22.99
16.77
14.29
16.46
Closing Cash & Equivalent
63.41
108.01
58.01
79.48
66.59
81.70
47.52
22.99
16.77
14.29

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
278.93
268.54
249.71
214.47
211.14
197.08
253.08
224.89
186.87
150.10
ROA
15.78%
13.12%
14.05%
12.24%
9.22%
9.54%
12.29%
13.79%
16.29%
20.64%
ROE
31.80%
26.79%
27.50%
23.29%
15.66%
14.28%
17.09%
18.32%
22.45%
26.60%
ROCE
43.04%
36.56%
37.29%
31.95%
25.52%
19.94%
24.17%
26.61%
32.75%
39.31%
Fixed Asset Turnover
1.44
1.36
2.00
2.02
2.19
2.20
3.63
4.65
3.95
2.85
Receivable days
55.11
63.43
62.76
71.65
66.00
72.08
57.82
72.61
66.42
59.81
Inventory Days
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Payable days
0.00
0.00
0.00
0.00
0.00
19.57
18.43
25.35
20.53
24.30
Cash Conversion Cycle
55.11
63.43
62.76
71.65
66.00
52.51
39.38
47.26
45.89
35.51
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
258.00
188.08
133.63
77.99
46.83
38.89
564.53
805.58
588.34
923.32

News Update:


  • MPS - Quarterly Results
    3rd Feb 2026, 00:00 AM

    Read More
  • MPS’ arm to acquire 100% stake in Unbound Medicine
    31st Jan 2026, 10:59 AM

    The acquisition represents a strategic milestone for MPS, marking its entry into the healthcare and medical information technology segment

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.